arsenic has been researched along with bicalutamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burnstein, KL; Rosenblatt, AE | 1 |
1 other study(ies) available for arsenic and bicalutamide
Article | Year |
---|---|
Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Nucleus; Cell Proliferation; Drug Evaluation, Preclinical; Drug Synergism; Humans; Male; Nitriles; Nuclear Receptor Coactivator 2; Oxides; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Protein Transport; Receptors, Androgen; Response Elements; Tosyl Compounds; Transcriptional Activation; Tumor Cells, Cultured | 2009 |